PCNA inhibitor AOH1996
Term · Oncology and biomedicine · MLC-T-ONC-015875
An orally bioavailable, small molecule inhibitor of proliferating cell nuclear antigen (PCNA), with potential chemo-sensitizing and antineoplastic activities. Upon oral administration, PCNA inhibitor AOH1996 penetrates cells and targets and binds to PCNA, preventing the binding of PCNA's interacting proteins to PCNA. This disrupts the interactions between PCNA and these proteins and may result in DNA replication stress and inhibition of DNA repair, which may enhance the efficacy of some antineoplastic agents and induce apoptosis. PCNA is a scaffold protein involved in multiple cellular processes via its interactions with many proteins.
| Identifier | MLC-T-ONC-015875 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | proliferating cell nuclear antigen inhibitor AOH1996 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015875",
"term": "PCNA inhibitor AOH1996",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable, small molecule inhibitor of proliferating cell nuclear antigen (PCNA), with potential chemo-sensitizing and antineoplastic activities. Upon oral administration, PCNA inhibitor AOH1996 penetrates cells and targets and binds to PCNA, preventing the binding of PCNA's interacting proteins to PCNA. This disrupts the interactions between PCNA and these proteins and may result in DNA replication stress and inhibition of DNA repair, which may enhance the efficacy of some antineoplastic agents and induce apoptosis. PCNA is a scaffold protein involved in multiple cellular processes via its interactions with many proteins.",
"synonyms": [
"proliferating cell nuclear antigen inhibitor AOH1996"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/pcna-inhibitor-aoh1996/"
}
Record 12,767 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.